Tom Rönnlund

ProstaLund is a Swedish medtech company and a leading developer and manufacturer of innovative urological devices and treatments. CoreTherm is a patented Thermotherapy treatment method for BPH which can be tailored to suit the needs of each individual patient. CoreTherm is used today in hospitals and clinics in Sweden and worldwide.

IPA Europe is the European branch of IPA, the International Probiotics Association, addressing policy issues related to probiotics in Europe. Officially established in February 2015, IPA Europe is an international non-profit organisation based in the heart of the European district in Brussels and registered in the EU Transparency Register. Interested in becoming a member or receiving further information? Please contact Mrs Rosanna Pecere at info@ipaeurope.org.

IPA Europe is the European branch of IPA, the International Probiotics Association, addressing policy issues related to probiotics in Europe. Officially established in February 2015, IPA Europe is an international non-profit organisation based in the heart of the European district in Brussels and registered in the EU Transparency Register. Interested in becoming a member or receiving further information? Please contact Mrs Rosanna Pecere at info@ipaeurope.org.

Turning data into better healthcare We transform healthcare data into actionable insights to help decision-makers, regulators and clinicians optimise the healthcare they provide. LOGEX is headquartered in Amsterdam, with over 400 international experts working in ten countries across Europe. To learn how LOGEX can bring clarity to your healthcare data, visit logex.com.

Observe Medical is a medtech company, listed on the Oslo Axess stock exchange, and with main operations in Sweden. Core product is Sippi®, the only digital urine measurement system for use in hospital intensive care units, with wireless data transfer to patient data management system and which also prevents bacterial migration which can lead to urinary infections.

Bonnier Healthcare Sweden - vi kunskapssäkrar vårdmötet Bonnier Healthcare är ett informationsföretag inom vård och life science. Vår målsättning är att kunskapssäkra varje vårdmöte. Våra tjänster riktar sig till: hälso- och sjukvårdspersonal, patienter och anhöriga samt läkemedelsbolag. ⚕️För dig som arbetar inom hälso- och sjukvården tillhandahåller vi bland annat kunskapsstödet Medibas, kunskapstester och digitala utbildningar. ⚕️För dig som patient och anhörig tillhandahåller vi bland annat hälsoportalen Netdoktor.se, patientutbildningar, webbinarium samt plattformen Aktiv Patient. ⚕️Till företag inom läkemedelsindustrin erbjuder bland annat GxP-utbildningar, business intelligence-lösningar och sponsrade läkarutbildningar. För ett hälsosammare Europa.

The Bonnier Group is the parent company in a group that includes several of the Nordic region's leading media companies. We have operations in a number of different areas with an emphasis on media, real estate and investments.

We are a CDMO based in Malmö, Sweden, that serves companies in the pharmaceutical and medical device industry. We provide comprehensive services from development through manufacturing on a contract basis. Together with our partners, we take innovations from idea to product.

ProstaLund is a Swedish medtech company and a leading developer and manufacturer of innovative urological devices and treatments. CoreTherm is a patented Thermotherapy treatment method for BPH which can be tailored to suit the needs of each individual patient. CoreTherm is used today in hospitals and clinics in Sweden and worldwide.

Redwood Pharma develops ophthalmic drugs in areas where medical need is especially great. This is an approach exemplified by our very first project. RP101 treats chronic dry eyes in post-menopausal women. Something that is possible thanks to our drug delivery platform IntelliGel, which controls the release of active substances. The platform also supports improved dosages of other established drugs. Dry eye disease (DED) offers enormous potential. A total of some 344 million people are affected, equivalent to a global market of USD 3.1 billion. And the market is expected to grow, not least due to the lack of effective treatments. This is something we want to change. Our strategy is to sign licence agreements with drug companies that will manufacture and market products on the global market. Redwood Pharma AB (publ.) is listed on the Nasdaq First North Growth Market (ticker: REDW, ISIN: SE008294789).

BLIS Technologies are the masters of the oral microbiome. We are dedicated to discovering, developing, and supplying clinically validated probiotic strains that support oral and upper respiratory health. We were the first to discover Streptococcus salivarius probiotics — BLIS K12™ and BLIS M18™ — and we’ve been leading the science of the oral cavity ever since. BLIS K12™ and BLIS M18™ are backed by decades of research, strong IP, and extensive clinical validation.

IPA Europe is the European branch of IPA, the International Probiotics Association, addressing policy issues related to probiotics in Europe. Officially established in February 2015, IPA Europe is an international non-profit organisation based in the heart of the European district in Brussels and registered in the EU Transparency Register. Interested in becoming a member or receiving further information? Please contact Mrs Rosanna Pecere at info@ipaeurope.org.